Skip to content

Adductor Canal Block in Outpatient Clinic for Pain Control After Knee Arthroplasty

Adductor Canal Block in Outpatient Clinic

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04883034
Acronym
ACB
Enrollment
60
Registered
2021-05-12
Start date
2020-06-01
Completion date
2021-06-01
Last updated
2021-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pain, Total Knee Arthroplasty

Brief summary

Single-shot Adductor Canal Block in the outpatient clinic is safe, significantly decreased pain and analgesic consumption and may enhance the rehabilitation program

Detailed description

The ACB in the outpatient clinic is safe and can minimize postoperative pain. The primary goal of this research was to see how ACB affected the Visual Analog Score (VAS) pain score during the rehabilitation as opposed to controls. The secondary goal was to determine how much analgesic (etoricoxibe) was consumed on a daily basis.

Interventions

PROCEDUREadductor canal block in outpatient clinic

perform adductor canal block in outpatient clinic for patient post total knee arthroplasty

DRUGAnalgesics, etoricoxibe

anaelgetic oral intake

Sponsors

Gadjah Mada University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
No minimum to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Indonesian or Javanese-speaking adults * After perfomed total knee replacement * American Society of Anesthesiologists physical status I-III * body mass index (BMI) of 18-40 kg/m2

Exclusion criteria

* Declined to complete the study * Unable to cooperate * had an allergic reaction to any of the drugs * abusing alcohol or drugs

Design outcomes

Primary

MeasureTime frameDescription
Visual analog pain score (VAS)one monthA VAS scale was used to assess pain severity, with 0 indicating no pain and 10 indicating extreme pain

Secondary

MeasureTime frameDescription
analgesic oral intake (etoricoxibe)one monthdetermine how much analgesic (etoricoxibe) was consumed on a daily basis.

Countries

Indonesia

Contacts

Primary Contactsholahuddin rhatomy, Dr
sholahuddin.rhatomy@ugm.ac.id+6281808720707

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026